B O E H R I N G E R I N G E L H E I M ( C A N A D A ) LT D . EQUINE PRODUCT GUIDE

WE HAVE YOU

COVERED

Buscopan® Injection for horses(HYOSCINE BUTYLBROMIDE)

• Buscopan® is indicated for the reduction of intestinal pain associated with non-surgical and uncomplicated colic in horses

• Buscopan® relieves pain caused by spasmodic and flatulent colic through its spasmolytic action

• Fast initial response. Most horses will respond within a few minutes• Studies have shown that 88% of Buscopan® - treated horses were rated by

veterinarians as a “success” with regards to the reduction of pain• Horses treated with Buscopan® showed an overall improvement in the

behavioural attitude. More horses were rated as “alert/calm” and were less likely to be “nervous/restless” than non-treated horses

Prascend®

(PERGOLIDE MESYLATE)

• Prascend® is indicated for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses

• It is currently the only Health Canada - approved treatment for PPID • Proven efficacy in clinical trials• Prascend® tablets are easily administered or dissolved, enhancing

palatability and horses’ acceptance• Prasend® is available in easy-to-open blister packs for convenience and for

protection from environmental conditions• Each box contains 60 tablets for convenient dispensing• Prascend® is stable for at least 24 months under label storage conditions

allowing for consistent, reliable dosing

Sedivet® 1% injection(ROMIFIDINE HYDROCHLORIDE)

• Sedivet® is indicated for use as a sedative to facilitate handling, examination, treatment and as a premedication agent prior to general anaesthesia

• Sedivet® allows standing sedation of adult horses• Sedivet® minimizes the typical head drop associated with other sedatives,

making it ideal for dental, endoscopic, and head- or neck-related procedures• Onset of sedation typically begins within one to two minutes and lasts for

40 to 80 minutes • Sedivet® patients generally recover quickly and without struggle or excitement

Sputolysin® Powder(DEMBREXINE)

• Sputolysin® is indicated as an aid in the treatment of respiratory diseases in the horse where there is difficulty in expectoration and where secretolysis is necessary or desirable

• Sputolysin® is bronchial mucolytic agent to aid in the treatment of respiratory disease in horses

• Sputolysin® alters the constituents and viscosity of abnormal respiratory mucus and improves the efficiency of the respiratory tract clearance mechanism

• Sputolysin® can also be used to treat horses with dry, irritating, non-productive coughs1

Ventipulmin®

(CLENBUTEROL HYDROCHLORIDE SYRUP)

• Ventipulmin® is indicated for the treatment of respiratory disease in horses where it is considered that airway obstruction is due to bronchospasm

• Bronchodilator for the management of airway constriction associated with respiratory disease in horses

• Causes smooth muscle in the airway to relax, allowing dilation of constricted airways

• Decreases thickness of mucus to help improve mucociliary transport2

• Safe and effective when used according to label directions

PHARMACEUTICALS

SUPPLEMENTSEquitop® Gonex® • Equitop® Gonex® supports and stimulates the mobility and maintenance of

healthy joints in horses

• Provides the raw ingredients for promoting the natural functioning of joints and connective tissue

• 100% natural source

Equitop® Myoplast® • Equitop® Myoplast® is a unique high quality amino acid supplement

• Provides the raw ingredients for lean muscle development

• 100% natural source

Equitop® Pronutrin® • Equitop® Pronutrin® maintains gastric health and provides extra nutrition in

various conditions, particularly beneficial in stressed horses

• Equitop® Pronutrin® contains 77% Apolectol®, a patented combination of fruit and vegetable fibre, glycerol and lecithin which prevents the increase of gastric acid and stabilizes the natural balance of the stomach mucous layer

2 mL syringe or 20 mL vial

10 mL vial

1 mL syringe

1 mL syringe

1 mL syringe

1 mL syringe, 10 mL vial

1 mL syringe, 10 mL vial

Calvenza® EIV/EHV

Vetera® 2XP

Vetera® WNV

Vetera® EWT

Vetera® EWT + WNV

Vetera® 5XP

Vetera® Gold XP

East

ern

(EEE

), W

este

rn

(WEE

) Enc

epha

lom

yelit

is

Wes

t Nile

Viru

s Nor

th

Amer

ican

Equ

ine

E159

™

Equi

ne In

fluen

za O

hio/

2003

Equi

ne In

fluen

za

New

mar

ket/

2/93

Equi

ne In

fluen

za K

y/95

Rhin

opne

umon

itis (

EHV-

1)Rh

inop

neum

oniti

s (EH

V-4)

Teta

nus T

oxoi

d

PRODUCT Equi

ne In

fluen

za

Rich

mon

d/20

07

SIZESCP

CP -

Cros

s Pr

otec

tion

Calvenza®

EQUINE INFLUENZA (EIV)/ RHINOPNEUMONITIS (EHV) VACCINE

• Calvenza® has been shown to provide protection from severe equine influenza challenge for at least 12 months following previous vaccination

• Calvenza® has been updated and contains the emerging Clade 1 North American EIV strain (Ohio/2003), as well as an established North American EIV strain (Kentucky/2/95). Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93)

• Calvenza® and Vetera® XP are currently the only vaccines sold in Canada that contain any of the EIV viruses currently recommended by the OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition

• Provides protection against both EHV-1 & EVH-4

• Safe, inactivated vaccine

• Flexible intranasal or intramuscular dose administration

Vetera® and Vetera® XPEQUINE INFLUENZA (EIV) / RHINOPNEUMONITIS (EHV), EASTERN - [EEE] /WESTERN- [WEE] ENCEPHALOMYELITIS, TETANUS

TOXOID AND WEST NILE VIRUS (WNV) COMBINATION VACCINES

• The new and updated Vetera® XP vaccines contain the OIE-recommended equine influenza viruses including the Richmond/07 strain

• Calvenza® and Vetera® XP are currently the only vaccines sold in Canada that contain any of the EIV viruses currently recommended by the OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition

• Incorporates a 2005 equine isolate of West Nile Virus that protects against the strains most likely to infect horses today

• 12 month duration of protection against WVN demonstrated using intrathecal WNV challenge method which is considered to be the gold standard for challenge studies

• Vetera® XP provides a 6 month DOI proven by challenge for EIV

VACCINES

Ventipulmin®

CLENBUTEROL HYDROCHLORIDESputolysin®

DEMBREXINE

No matter what type of horse you have, we have you covered.

Products shown are registered trademarks of Boehringer Ingelheim Vetmedica GmbH or Boehringer Ingelheim Vetmedica, Inc. Licensed to Boehringer Ingelheim (Canada) Ltd.©2017 Boehringer Ingelheim (Canada) Ltd./Ltée. All rights reserved. CA/VETE-161023

REFERENCES:1. Matthews, A.G. The mucolytic effect of Sputolosin in horses with respiratory disease. Veterinary record. Vet Rec Jan 30, 1988. v. 122 (5) 2. Robinson N. E. Clenbuterol and the Horse. AAEP Proceedings. December 2000. Vol. 46. 229-233.

For more information, please contact your Boehringer Ingelheim (Canada) Ltd. Territory Manager or call Customer Care at 1-800-567-1885.For technical support on any of our products, please call 1-877-565-5501.